You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
高視醫療(02407.HK)眼底相機獲得中國醫療器械註冊證
格隆匯 06-19 18:44

格隆匯6月19日丨高視醫療(02407.HK)公吿,近日公司附屬公司高視創新科技有限公司("高視創新")"眼底相機"已獲得由江蘇省藥品監督管理局批准的醫療器械註冊證。

隨着人口老齡化進程加快以及糖尿病、高血壓等慢性病發病率上升,眼底疾病患者數量持續增長。糖尿病視網膜病變、老年性黃斑變性、青光眼等眼底疾病若不及時干預,可能導致不可逆的視力損傷甚至失明。然而,傳統的眼底檢查往往依賴散瞳操作,不僅增加患者不適感,還延長了檢查時間。

高視創新本次獲批的眼底相機(註冊證編號:蘇械注準20252161082)集成了智能成像系統與創新免散瞳高清成像技術,實現了從對焦、拍攝到圖像優化的全流程自動化操作。該設備搭載智能追蹤技術可自動識別瞳孔位置並完成精準對焦,通過先進光學系統設計實現非接觸式高清成像,免除傳統散瞳藥物帶來的不適感,一鍵即可獲取清晰呈現視網膜微細結構的診斷級圖像。其特有的智能引導系統可自動調整拍攝參數適應不同患者特徵,配合先進的圖像處理算法自動優化拍攝效果,全封閉式檢查流程最大限度降低人為干擾。產品嚴格遵循國際光安全標準,優化光源和人體工學設計確保檢查安全舒適,支持多種圖像格式存儲和便捷數據導出,完美對接醫院信息系統。

本產品適用於糖尿病視網膜病變等多種眼底疾病的篩查診斷和長期隨訪,使非專業操作人員也能輕鬆完成專業級眼底檢查,真正實現"一鍵拍,自動好"的智能化診療體驗,顯著提升基層醫療機構的眼科診療能力,推動眼健康篩查的普及化發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account